ozempic novo nordisk news - Search News

Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have been associated with at least 100 hospitalizations and 10 deaths, the chief executive of Ozempic maker Novo Nordisk warned Wednesday.

Seeking Alpha · 20h

Novo Nordisk aware of 10 deaths related to weight-loss drug copies - report

Novo Nordisk (NVO) is aware of 10 deaths and 100 hospitalizations of people that took copycat versions of its popular drugs Wegovy and Ozempic, its CFO Karsten Munk Knudsen told a media

Reuters on MSN · 14h

Novo Nordisk aware of reports 10 people taking compounded weight-loss drug copies died

Novo Nordisk chief financial officer Karsten Munk Knudsen said on Wednesday the company was aware of reports of 10 deaths and 100 hospitalisations of people who had taken compounded copies of its weight-loss and diabetes drugs.

3don MSN

Scientist behind Novo Nordisk's Ozempic, Wegovy started her career developing laundry detergent

Novo Nordisk scientist Lotte Knudsen, whose research led to Ozempic and Wegovy, started her career developing laundry ...

Investopedia on MSN14h

Novo Nordisk Stock Slips as Sales Grow Less Than Expected

After rising in premarket trading, Novo Nordisk's U.S.-listed shares fell after the market opened Wednesday as its ...

FiercePharma10h

After Lilly's GLP-1 sales fumble, Novo reports mixed results on Ozempic, Wegovy

Following a disappointing earnings showing from Eli Lilly last week, Novo Nordisk’s latest report on the performance of its ...

3don MSN

Ozempic, Wegovy sales inject wealth into Novo Nordisk home country of Denmark

Drugs Ozempic and Wegovy have slimmed down Hollywood stars — and millions of non-celebrities worldwide— while adding great ...

FierceBiotech1d

Novo Nordisk discards kidney disease drug from $1.3B deal in wake of phase 3 fail

Novo Nordisk, after mulling the implications of a phase 3 fail ... the only CKD program still listed in Novo’s pipeline ...

22hon MSN

Novo Nordisk shares jump 8% after Wegovy sales beat expectations

Novo Nordisk on Wednesday reported third quarter earnings broadly in line with expectations, said that its net profit in the ...

1d

Novo Nordisk: A GLP-1 Leader Faces Increasing Competition

Novo Nordisk's valuation remains high, trading at a significant historical premium. Click here to see why NVO stock is a Sell ...

14hon MSN

Novo Nordisk Shares Climb as Wegovy Sales Reassure Investors

Novo Nordisk A/S shares rose as surging sales of the blockbuster weight-loss treatment Wegovy reassured investors after rival ...

Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

Semaglutide, the scientific name for Novo’s GLP-1 diabetes drug Ozempic and obesity drug Wegovy, has been on the shortage ...

12h

Novo Nordisk expects high demand for its obesity drugs in India, says country head

Popular weight-loss drug Wegovy maker Novo Nordisk expects high demand and acceptance for its anti-obesity drug, when ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results